Last reviewed · How we verify

NCT03094481

Interscalene vs. Superficial Cervical Block vs. Combination for Analgesia After Clavicle Fracture

Status unknown NA Last updated 3 May 2018
What this trial tests

NA trial testing SCPB in Clavicle Fracture in 120 participants. Status unknown.

Timeline
21 October 2016
Primary endpoint
1 November 2019
1 March 2020

Quick facts

Lead sponsorSunnybrook Health Sciences Centre
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment120
Start date21 October 2016
Primary completion1 November 2019
Estimated completion1 March 2020
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Sunnybrook Health Sciences Centre — full company profile →

Who can join

Adults 18 to 85, any sex, with Clavicle Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The optimal analgesic peripheral nerve block (or combinations thereof) are undefined for clavicle fractures, the most frequent fracture in the human population. This goal of this study is to determine whether interscalene block (ISB), superficial cervical plexus block (SCPB), or both provide the best analgesia for lateral and midshaft clavicular fractures, respectively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Clavicle Fracture

Currently open trials in the same condition.

Other Sunnybrook Health Sciences Centre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03094481.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing